GLP-1s are predicted to become the best-selling drug class of 2024 (inclusive of diabetes and obesity) 2 The late-stage obesity pipeline is dominated by big pharma, and 8 of the top 20 pharma companies have a clinical stage asset in development The obesity pipeline has almost tripled in size since June 2023, and there are up to 6 new U.S
Mora, S
Caviar and fish roe substitutes: Current status of their nutritive value, bio-chemical diversity, authenticity and quality control methods with future perspectives
Belema-Bedada F, Uchida S, Martire A, Kostin S, Braun T
Semaglutide (Wegovy, Ozempic) Semaglutide is a GLP-1 receptor agonist with 94% sequence homology to human GLP-1
When an unopened Ozempic pen is accidentally left out of the refrigerator overnight, the impact depends on the ambient temperature and duration of exposure